Skip to main content
Premium Trial:

Request an Annual Quote

Reagent Shop Imgenex Opens R&D Facility in India

NEW YORK, Jan. 5 (GenomeWeb News) - Imgenex opened an R&D facility in India last week, the San Diego-based company said yesterday.

 

Privately held Imgenex develops and sells reagents including antibodies, gene- and protein-expression systems, and arrays of various cells and tissues for use in research studies. Areas of biological interest include cancer, apoptosis, molecular signaling pathways, cellular aging, and metabolic and infectious diseases.

 

Imgenex India, located in Bhubaneswar, is staffed by approximately 80 scientists, the company told GenomeWeb News.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.